These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31959227)

  • 1. Methylome and transcriptome analyses reveal insights into the epigenetic basis for the good survival of hypomethylated ER-positive breast cancer subtype.
    Chen XQ; Zhang F; Su QC; Zeng C; Xiao FH; Peng Y
    Clin Epigenetics; 2020 Jan; 12(1):16. PubMed ID: 31959227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the nexus between the tumor immune microenvironment and DNA methylation in subgrouping estrogen receptor-positive breast cancer.
    Chen XQ; Zhang F; Xiao FH; Peng Y
    Breast Cancer; 2021 Nov; 28(6):1252-1260. PubMed ID: 33966175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence.
    Fackler MJ; Umbricht CB; Williams D; Argani P; Cruz LA; Merino VF; Teo WW; Zhang Z; Huang P; Visvananthan K; Marks J; Ethier S; Gray JW; Wolff AC; Cope LM; Sukumar S
    Cancer Res; 2011 Oct; 71(19):6195-207. PubMed ID: 21825015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis.
    Romagnolo DF; Papoutsis AJ; Laukaitis C; Selmin OI
    BMC Cancer; 2015 Dec; 15():1026. PubMed ID: 26715507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential methylation and expression patterns of microRNAs in relation to breast cancer subtypes among American women of African and European ancestry.
    Gong Z; Chen J; Wang J; Liu S; Ambrosone CB; Higgins MJ
    PLoS One; 2021; 16(3):e0249229. PubMed ID: 33784351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation and hormone receptor status in breast cancer.
    Benevolenskaya EV; Islam AB; Ahsan H; Kibriya MG; Jasmine F; Wolff B; Al-Alem U; Wiley E; Kajdacsy-Balla A; Macias V; Rauscher GH
    Clin Epigenetics; 2016; 8():17. PubMed ID: 26884818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes.
    Li Y; Li S; Chen J; Shao T; Jiang C; Wang Y; Chen H; Xu J; Li X
    Hum Mol Genet; 2014 Oct; 23(20):5378-93. PubMed ID: 24871326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer.
    Awada Z; Nasr R; Akika R; Cahais V; Cuenin C; Zhivagui M; Herceg Z; Ghantous A; Zgheib NK
    Clin Epigenetics; 2019 Oct; 11(1):138. PubMed ID: 31601247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of the claudin 1 promoter is associated with loss of expression in estrogen receptor positive breast cancer.
    Di Cello F; Cope L; Li H; Jeschke J; Wang W; Baylin SB; Zahnow CA
    PLoS One; 2013; 8(7):e68630. PubMed ID: 23844228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer.
    Snider H; Villavarajan B; Peng Y; Shepherd LE; Robinson AC; Mueller CR
    Clin Epigenetics; 2019 Nov; 11(1):155. PubMed ID: 31675993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowly methylated region analysis identifies EBF1 as a potential epigenetic modifier in breast cancer.
    Fernandez-Jimenez N; Sklias A; Ecsedi S; Cahais V; Degli-Esposti D; Jay A; Ancey PB; Woo HD; Hernandez-Vargas H; Herceg Z
    Epigenetics; 2017; 12(11):964-972. PubMed ID: 29099283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative methylation of intron motifs is associated with cancer-related gene expression in both canine mammary tumor and human breast cancer.
    Nam AR; Lee KH; Hwang HJ; Schabort JJ; An JH; Won SH; Cho JY
    Clin Epigenetics; 2020 Jul; 12(1):110. PubMed ID: 32693820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing.
    Sun Z; Asmann YW; Kalari KR; Bot B; Eckel-Passow JE; Baker TR; Carr JM; Khrebtukova I; Luo S; Zhang L; Schroth GP; Perez EA; Thompson EA
    PLoS One; 2011 Feb; 6(2):e17490. PubMed ID: 21364760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation profile of inflammatory breast cancer and its impact on prognosis and outcome.
    Faldoni FLC; Bizinelli D; Souza CP; Santana IVV; Marques MMC; Rainho CA; Marchi FA; Rogatto SR
    Clin Epigenetics; 2024 Jul; 16(1):89. PubMed ID: 38971778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers.
    de Almeida BP; Apolónio JD; Binnie A; Castelo-Branco P
    BMC Cancer; 2019 Mar; 19(1):219. PubMed ID: 30866861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
    Yi L; Luo P; Zhang J
    J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The circadian gene CRY2 is associated with breast cancer aggressiveness possibly via epigenomic modifications.
    Mao Y; Fu A; Hoffman AE; Jacobs DI; Jin M; Chen K; Zhu Y
    Tumour Biol; 2015 May; 36(5):3533-9. PubMed ID: 25740058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and progesterone receptor status affect genome-wide DNA methylation profile in breast cancer.
    Li L; Lee KM; Han W; Choi JY; Lee JY; Kang GH; Park SK; Noh DY; Yoo KY; Kang D
    Hum Mol Genet; 2010 Nov; 19(21):4273-7. PubMed ID: 20724461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrichment of CpG island shore region hypermethylation in epigenetic breast field cancerization.
    Muse ME; Titus AJ; Salas LA; Wilkins OM; Mullen C; Gregory KJ; Schneider SS; Crisi GM; Jawale RM; Otis CN; Christensen BC; Arcaro KF
    Epigenetics; 2020 Oct; 15(10):1093-1106. PubMed ID: 32255732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.